|
|
||||||||
2-deficient mice
Biozentrum, University of Basel, Basel, Switzerland
1Correspondence: Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland. E-mail: markus-a.ruegg{at}unibas.ch
Mutations in the gene encoding the
2 subunit of laminins cause the severe "merosin-deficient congenital muscular dystrophy" (MDC1A). We have recently shown that overexpression of a miniaturized form of the molecule agrin (mini-agrin) counteracts the disease in dyW/dyW mice, a model for MDC1A. However, these mice express some residual truncated laminin-
2, suggesting that the observed amelioration might be due to mini-agrins presenting the residual laminin-
2 to its receptors. Here we show that the mini-agrin counteracts the disease in dy3K/dy3K mice, which are null for laminin-
2. As in dyW/dyW mice, mini-agrin improves both the function and structure of muscle. We show that muscle regeneration after injury is severely impaired in dy3K/dy3K mice but is restored in the mini-agrin-expressing littermates. In summary, our results 1) show that the direct linkage of muscle basal lamina with the sarcolemma is the basis of mini-agrin-mediated amelioration and 2) provide unprecedented evidence that this linkage is important for proper regeneration of muscle fibers after injury. Our findings thus suggest that treatment with mini-agrin might be beneficial over the entire spectrum of the MDC1A disease, whose severity inversely correlates with expression levels and the size of the truncation in laminin-
2.Bentzinger, C. F., Barzaghi, P., Lin, S., Ruegg, M. A., Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-
2-deficient mice.
Key Words: muscular dystrophy laminin-
2 deficiency muscle regeneration
This article has been cited by other articles:
![]() |
R. Xu, K. Chandrasekharan, J. H. Yoon, M. Camboni, and P. T. Martin Overexpression of the Cytotoxic T Cell (CT) Carbohydrate Inhibits Muscular Dystrophy in the dyW Mouse Model of Congenital Muscular Dystrophy 1A Am. J. Pathol., July 1, 2007; 171(1): 181 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meinen, P. Barzaghi, S. Lin, H. Lochmuller, and M. A. Ruegg Linker molecules between laminins and dystroglycan ameliorate laminin-{alpha}2-deficient muscular dystrophy at all disease stages J. Cell Biol., March 26, 2007; 176(7): 979 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Scotton, D. Bleckmann, M. Stebler, F. Sciandra, A. Brancaccio, T. Meier, J. Stetefeld, and M. A. Ruegg Activation of Muscle-specific Receptor Tyrosine Kinase and Binding to Dystroglycan Are Regulated by Alternative mRNA Splicing of Agrin J. Biol. Chem., December 1, 2006; 281(48): 36835 - 36845. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |